Inclusion Criteria:  Healthy, male or female subjects between 30 and 70 years of age. Able to read, understand and voluntarily provide written Informed Consent. Able and willing to comply with the treatment/follow-up schedule and requirements. Women of childbearing age are required to be using a reliable method of birth control at least 3 months prior to study enrollment and for the duration of the study and have a negative Urine Pregnancy test at baseline. Subjects may have any Fitzpatrick skin type, however, no more than 25% of subjects may have Fitzpatrick skin type V or VI.  Exclusion Criteria:  Previous aesthetic (device and/or surgical) skin treatment in the treated areas (under arms and/or behind the ear) in the previous 6 months. Fat, collagen, silicone, tattoos, body jewelry, that cannot be removed for the duration of treatment and tegaderm/glue application or any other synthetic material in the treatment area. History of keloid formation Active smoker or having quit smoking in the last 3 months. Active, chronic, or recurrent infection Compromised immune and/or healing system (e.g. diabetes) Hypersensitivity/allergy to analgesic agents. Co-morbid condition that could limit the ability to participate in the study or to comply with follow-up requirements. Pregnant or breastfeeding Any indication that may cause excessive bleeding, e.g., anticoagulants. Carcinoma, melanoma, or any other cancerous condition in the last 6 months. Allergy to adrenaline, epinephrine, or Tranexamic acid (TXA). Currently or in the last 1-month part of another clinical study of an investigational drug and/or experimental medical device Any issue that, at the discretion of the investigator would contra-indicate the subject's participation.